Lung function and exhaled nitric oxide levels in infants developing chronic lung disease

Area of Science:

• Neonatal Medicine
• Pediatric Pulmonology
• Respiratory Physiology

Background:

• Chronic lung disease (CLD) is a frequent complication following neonatal intensive care.
• Predicting CLD development is crucial for timely intervention and improved outcomes in preterm infants.

Purpose of the Study:

• To compare serial exhaled nitric oxide (eNO) measurements in infants who developed CLD versus those who did not.
• To evaluate the predictive value of eNO, lung function tests (FRC, CRS), and clinical data (gestational age, birthweight) for CLD development.

Main Methods:

• Serial measurements of eNO, functional residual capacity (FRC), and compliance of the respiratory system (CRS) were performed on 24 preterm infants (median gestational age 27 weeks) on multiple postnatal days.
• Receiver operator characteristic (ROC) curves were constructed to assess the predictive accuracy of different parameters for CLD development.

Main Results:

• Infants who developed CLD had significantly lower birthweight and gestational age.
• Lower median FRC and CRS values were observed in the first week of life for infants who developed CLD (P < 0.02).
• Exhaled nitric oxide (eNO) levels did not differ significantly between the groups and were not predictive of CLD.

Conclusions:

• Early lung function tests, particularly FRC and CRS on Day 3, are strong predictors of CLD development in preterm infants.
• Lung function test results are more predictive than eNO levels.
• While useful, early lung function tests are not significantly superior to birthweight in predicting CLD.